About Agena Bioscience
Agena Bioscience is dedicated to advancing the impact of genomics in healthcare and precision medicine. Our highly sensitive and cost-effective mass spectrometry-based platform, the MassARRAY® System, is used globally in diverse fields such as cancer profiling for solid tumors and liquid biopsies, inherited genetic disease testing, pharmacogenetics, agricultural genomics, and clinical research.
Our mission is to equip genomic and clinical testing laboratories with practical solutions that increase productivity and decrease time to results. Whether assessing sample quality, screening samples for actionable mutations, or enabling routine genetic testing for tens to thousands of samples, our products and services help laboratories translate genomic discoveries into mainstream clinical practice.
Agena Bioscience was formed in 2014, when Telegraph Hill Partners (THP) acquired the Biosciences Division of Sequenom Inc. THP is a life sciences investment firm that focuses on providing growth capital to life science, medical device, and healthcare product companies.
Agena Bioscience is headquartered in San Diego, CA, and markets its products in over 30 countries worldwide through direct sales offices in Germany, China, Japan, and Australia, and through an extensive network of distributors.
Agena Bioscience Brands:
- MassARRAY® System for highly multiplexed nucleic acid detection
- iPLEX® chemistry for genotyping, copy number variation, and somatic mutation profiling
- UltraSEEK™ chemistry for rare mutation detection
- EpiTYPER® application for methylation analysis
Learn more about Agena Bioscience, and how to connect with us: